Publication | Open Access

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

Tp53 StatusBreast OncologyMedicineRandomised Phase 3PathologyBreast CancerBiostatisticsCancer TreatmentOncologyTumor Biology